Professional Development
This webinar will focus on the latest research findings from international experts presented at the ACC 2026. These perspectives can impact profound changes and improvements in their clinical approach.
Program Learning Objectives:
– To review new data relevant to clinical practice
– To discuss the latest clinical trial data from ACC 2026 and apply it to daily practice
Program Chair & Moderator: Dr. Anil Gupta
Discussants: Dr. Chris Overgaard, Dr. Jonathan Howlett, and Dr. Margot Davis
Trials Covered:
- Long-Term Survival Benefits and Disease Stabilization With Acoramidis In Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Spironolactone in the Treatment of Heart Failure (SPIRIT-HF)
- CHIP BCIS3 – Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention